Navigation Links
nanoTox COO Greg King Advises Nanotech Companies to View Safety Concerns as an Opportunity to Gain Consumer Trust
Date:4/7/2010

nanoTox COO Greg King responded to the AOL News series, “The Nanotech Gamble,” with advice for nano-product companies on how to turn concerns over nanotechnology into consumer relations wins.

Austin, TX (Vocus) -- Responding to a series of AOL News articles questioning the oversight of nanotechnology product safety (http://www.aolnews.com/category/nanotech/), nanoTox COO Greg King said that nano-product companies will need to confront possible negative perceptions directly to avoid the kinds of public outcry experienced by bioengineered food companies in the past.

“It’s in people’s nature to fear the unknown,” said King. “And while companies may not be able to educate everyone in the complexities of nanotechnology, they can turn safety concerns to their advantage by being transparent about its use in their products, documenting their careful research and emphasizing concern over human and environment health.”

King was responding to AOL News and Pulitzer Prize-winning reporter Andrew Schneider, who published a series entitled “The Nanotech Gamble” which explored possible risks that may accompany nanotechnology research and product development. Schneider’s series was greeted with concern by most in the U.S. nanoproduct industry.

“Schneider’s articles expresses quite well the public’s concern about nanomaterials.” King added. “No new technology gains wide consumer acceptance until potential safety concerns are addressed and resolved.

“Companies wanting to successfully commercialize products that contain nanomaterials will need to address those safety concerns. This is especially true for nanoproducts that have direct human contact, such as textiles, foods, medicines, cosmetics, personal care products. The companies that can demonstrate that their products are safe will have a competitive advantage.”

King is the author of several articles on nanotechnology risk management and nanotechnology regulation. King’s company, nanoTox, is the first to provide complete risk assessment and solutions exclusively for nanoparticles.

“The nanotech revolution is one of the best opportunities for cosmetic, food, and other companies incorporating nanoparticles to build new trust with their existing and future customers,” said King. “By showing that they are ahead of the game, they can inoculate themselves against negative perceptions and even champion themselves as leaders in product safety.”

About nanoTox™, Inc.
nanoTox is the first company to provide complete risk assessment – and solutions – exclusively for nanoparticles. nanoTox can help companies commercialize their products by helping address safety issues and responding to regulatory requirements.

nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation and for acceptance by the insurance industry.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability. For more information, visit www.nanotox.com.

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3846944.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Burrill Merchant Banking Advises NPS on Phase III Licensing Agreement
2. Burrill Merchant Banking Advises Faes Farma on Bilastine Licensing Agreement
3. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
4. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
5. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
6. KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd
7. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
8. NASA technology forms the basis for a new nanotechnology company
9. Superbugs, shapes and nanotechnology
10. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
11. Nanotech could make solar energy as easy and cheap as growing grass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... REDWOOD CITY, Calif. , Feb. 27, 2017 ... specialty pharmaceutical company focused on the development and ... moderate-to-severe acute pain, announced today the U.S. Food ... New Drug Application (NDA) under section 505(b)(2) for ... for the treatment of patients with moderate-to-severe acute ...
(Date:2/27/2017)... and HAMILTON, Bermuda , ... (NASDAQ: ADXS ) and SELLAS ... focused on developing cancer immunotherapies, today announced that ... a novel cancer immunotherapy agent using Advaxis, proprietary ... patented WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/27/2017)... Iowa (PRWEB) , ... February 27, 2017 , ... In ... following the advice of his grandfather, “Hire for attitude. Train for skill.” , In ... University star linebacker Jevohn Miller as a salesman. Zamzow is hoping to replicate the ...
(Date:2/26/2017)... ... 26, 2017 , ... Rob Lowe is a well recognized television personality, so ... focuses on issues that are important to the American public and important to society ... been a hot topic around the world for a few years. , The climate ...
Breaking Biology Technology:
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
(Date:1/25/2017)... The Elements of Enterprise Information Security ... of a comprehensive set of business processes and ... identities and providing a secured and documented access ... number of programs opted by enterprises to maintain ... processes and changing policies. However, there are some ...
Breaking Biology News(10 mins):